Pharmaceutical Care Practice and Consequences on Quality of Life and Satisfaction of Diabetic Patients: A Randomized Clinical Trial

Abstract The pursuit of quality of life, which has become marked in recent years, has translated into important population health benefits. This study assessed the quality of life of patients with type 2 diabetes (T2DM) who received pharmaceutical care, and their satisfaction with the service provided in community pharmacies. This single blind, randomized controlled clinical trial included 100 patients. The intervention group (N=47) received pharmaceutical care by a clinical pharmacist and the control group (N=42) received standard care. The Quality of Life Diabetes Questionnaire (DQOL) was used to measure all participants´ quality of life at study enrollment and six months later. Satisfaction of the participants in the intervention group was measured using a validated 14-items questionnaire. At the end of the study, participants in the intervention group had a statistically significant improvement in DQOL scores ( -0.62 x 1.57, p < 0.001) and were highly satisfied with the intervention (96% excellent satisfaction scores). Pharmaceutical care practice was associated with high satisfaction and increased quality of life scores in T2DM patients. These results underscore the important role of pharmacists to improve the health of diabetic patients.

Prevalence and risk factors of inadequate medicine home storage: a community-based study.

OBJECTIVE: Assess the extent of inadequate home storage of medicines andidentify important risk factors. METHODS: A cross-sectional survey based on a probability sample in the community, conducted in 267 households in Cuité, State of Paraíba, Northeast Brazil, in 2014. Logistic regression was used to study the risk factors. RESULTS: The prevalence of households with inadequate storage was 76.0%. Problems with storage include direct exposure to sunlight in 10.9% of households, the presence of dust in 23.6%, and storage within reach of children in 76.0%. Medications no longer used are usually disposed of into the environment in 92.1% of households. Inadequate storage is more likely when home organization of medications is the responsibility of a male subject (OR = 1.729) or an older person (OR = 1.029), when out of date medicines are found (OR = 2.963), and in households with no children (OR = 2.088). CONCLUSIONS: Physicians and pharmacists should advise patients on how to adequately store medicines at home, especially when the person in charge of medications is a male or an older adult, and if there are no children in the household.

Prevalence and risk factors of inadequate medicine home storage: a community-based study

ABSTRACT OBJECTIVE Assess the extent of inadequate home storage of medicines andidentify important risk factors. METHODS A cross-sectional survey based on a probability sample in the community, conducted in 267 households in Cuité, State of Paraíba, Northeast Brazil, in 2014. Logistic regression was used to study the risk factors. RESULTS The prevalence of households with inadequate storage was 76.0%. Problems with storage include direct exposure to sunlight in 10.9% of households, the presence of dust in 23.6%, and storage within reach of children in 76.0%. Medications no longer used are usually disposed of into the environment in 92.1% of households. Inadequate storage is more likely when home organization of medications is the responsibility of a male subject (OR = 1.729) or an older person (OR = 1.029), when out of date medicines are found (OR = 2.963), and in households with no children (OR = 2.088). CONCLUSIONS Physicians and pharmacists should advise patients on how to adequately store medicines at home, especially when the person in charge of medications is a male or an older adult, and if there are no children in the household.

Criptococcose: revisão sistemática dos casos ocorridos no Brasil entre 1995-2005 / Cryptococcus neoformans: systematic review of the cases occurred in Brazil

Neste artigo, apresenta-se uma revisão sistemática da literatura científica a respeito dos casos clínicos de criptococose ocorridos no Brasil. Foram selecionados trabalhos publicados na PUBMED, entre os anos de 1995 e 2005, totalizando 13 publicações, nas quais se encontram casos clínicos em pacientes com ou sem AIDS. Nove desses estudos ocorreram nas regiões Centro-Oeste, Sul e Sudeste, e três deles envolvem a região Norte e Nordeste. Foram verificadas as seguintes variáveis: autor (es), ano, localidade, número de casos investigados, agente(s) etiológico(s), sinais e sintomas, doença isolada ou associada, resposta imune e desfecho. Pôde-se constatar que a maior parte dos casos relatados ocorreu como co-infecção associada a Aids, sendo o agente etiológico mais freqüente o Cryptococcus neoformans var. neoformans (sorotipos A e D). Esses casos foram encontrados com maior prevalência nas regiões Sul, Sudeste e Centro-Oeste. A ocorrência de C neoformans var. gattii (sorotipos B e C) está relacionada com áreas endêmicas, localizadas na região Norte e Nordeste. Os sinais e sintomas afetam, principalmente, o Sistema Nervoso Central e os pulmões. Os casos relatados na literatura apresentam limitações quanto ao desfecho da criptococose, possivelmente, devido ao fato de a patologia se desenvolver, principalmente, como uma co-infecção relacionada à Aids.